W39
(6M)-3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide
Find entries where: W39
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | (6M)-3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide |
Identifiers | 3-azanyl-~{N}-[3-(4-azanyl-4-methyl-piperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide |
Formula | C22 H23 F3 N8 O |
Molecular Weight | 472.466 |
Type | NON-POLYMER |
Isomeric SMILES | CC1(CCN(CC1)c2cccnc2NC(=O)c3c(ncc(n3)c4c(cccn4)C(F)(F)F)N)N |
InChI | InChI=1S/C22H23F3N8O/c1-21(27)6-10-33(11-7-21)15-5-3-9-29-19(15)32-20(34)17-18(26)30-12-14(31-17)16-13(22(23,24)25)4-2-8-28-16/h2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34) |
InChIKey | XXJXHXJWQSCNPX-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 57 |
Chiral Atom Count | 0 |
Bond Count | 60 |
Aromatic Bond Count | 18 |
Drug Info: DrugBank
DrugBank ID | DB16059 |
---|---|
Name | Darovasertib |
Groups | investigational |
Description | IDE-196 is under investigation in clinical trial NCT03947385 (Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions). |
Synonyms | Darovasertib |
CAS number | 1874276-76-2 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL3982723 |
PubChem | 118873253 |
ChEMBL | CHEMBL3982723 |